Nanotechnology Now

Our NanoNews Digest Sponsors



Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > UC Santa Barbara and Burnham Institute for Medical Research Announce Director of New Joint Research Center for Nanomedicine

Jamey D. Marth
Jamey D. Marth

Abstract:
UC Santa Barbara and Burnham Institute for Medical Research Announce Director of New Joint Research Center for Nanomedicine

UC Santa Barbara and Burnham Institute for Medical Research Announce Director of New Joint Research Center for Nanomedicine

Santa Barbara, CA | Posted on August 12th, 2009

The Burnham Institute for Medical Research and the University of California, Santa Barbara have named leading biomedical researcher Jamey D. Marth director of a new joint Center for Nanomedicine that will be established at UCSB.

The collaborative biomedical research partnership merges UCSB's core expertise in engineering, materials sciences, nanotechnology, and physics with Burnham's strengths in the biological sciences and biomedical research. The new center will promote the convergence of these fields and pioneer the development of novel technologies for advancing human health. Together, UCSB and Burnham plan to recruit additional scientists to the Center for Nanomedicine to create collaborative research teams that will produce innovative technologies for an entirely new generation of biosensors, medical devices, drug delivery nanoparticles, instruments for advanced biomedical research, and other products.

Nanomedicine, an offshoot of nanotechnology, refers to highly specific medical intervention at the molecular scale for curing disease or repairing damaged tissues, such as bone, muscle, or nerve.

"Interdisciplinary nanotechnologies are vital to establishing a holistic and rigorous approach to biomedical research that encompasses disparate knowledge and integrates all of the cellular molecules and factors that contribute to disease," said Marth, who joined UCSB's faculty in the Department of Molecular, Cellular, and Developmental Biology (MCDB), as well as Burnham's faculty, on July 1.

At UCSB, Marth has been appointed to two prestigious endowed professorships. He is the first recipient of both the John Carbon Chair in Biochemistry and Molecular Biology and the Duncan and Suzanne Mellichamp Chair in Systems Biology in the campus's Biomolecular Science and Engineering Program. Prior to joining Burnham and UCSB, Marth was professor of cellular and molecular medicine and Howard Hughes Medical Institute Investigator at the UC San Diego School of Medicine.

"With appointments to both UCSB and Burnham, I look forward to building further bridges between the talented scientists at these institutions and to promoting our joint efforts to develop nanotechnologies for disease diagnosis, prevention, therapy, and cure," said Marth. "This new and timely initiative will require the expertise of engineers, physicists, bioinformatics experts, and materials scientists working in close collaboration with biologists, that builds on the complementary expertise that exists at UCSB and the Burnham Institute for Medical Research."

Marth's laboratory is world-renowned in the application of cellular biology to uncovering the origins of disease. Marth is engaged in collaborative projects with UCSB and Burnham Institute scientists to develop nanotechnology platforms for biomedical research, including the means to rapidly detect and manipulate the cellular components that are responsible for health and disease. His highly interdisciplinary research has led to the discovery of disease mechanisms that span multiple fields, including autoimmune disease, infectious disease, and dietary-induced Type 2 diabetes.

"We are pleased to welcome an elite scientist like Dr. Marth to Burnham and to this collaborative partnership with UCSB in the exciting field of nanomedicine," said Dr. John Reed, Burnham's president and chief executive officer, and professor and Donald Bren Presidential Chair at the institute. "The impact of our collaborative efforts will be far-reaching, not only in terms of advancing the science of nanomedicine, but in terms of economic development opportunities for new company generation and job creation."

Pierre Wiltzius, Worster Dean of Science and professor of physics at UCSB, noted that Marth will play a central role in shaping the future of biomedical research on campus and described him as a "truly stellar biomolecular scientists who merits these prestigious endowed chairs."

"The coupling of biomolecules to nanomaterials and their assembly into nanostructures will produce a wide range of ‘smart' devices with an enormous breadth of practical applications, including diagnostics and biosensors, drug screening and delivery, tissue engineering, and much more," Wiltzius added. "The impact of this new field of science, termed ‘nanomedicine,' on medicine and life sciences will be hugely transformative, comparable in magnitude to the transition from transistors to silicon chips in the computer sciences."

Larry Coldren, acting dean of UCSB's College of Engineering and Kavli Professor of Optoelectronics and Sensors, described the new center's collaborative opportunities in nanomedicine and systems biology as a "perfect complement" to research underway at UCSB on networked systems approaches to drug development and therapies. "The combination of Jamey Marth's interests in disease mechanisms with our strengths in bioengineering and computational and materials sciences will be highly synergistic, and could well lead to major advances in therapies for grievous human diseases," he said.

Burnham established an affiliation with UCSB in 2006, led by internationally renowned biomedical researcher Erkki Ruoslahti, M.D., Ph.D. Dr. Ruoslahti maintained his primary appointment as Distinguished Professor with Burnham and joined UCSB's Department of Molecular, Cellular, and Developmental Biology as an adjunct Distinguished Professor. This type of collaboration, involving a highly ranked university and a nonprofit, independent research institute, exemplifies the inherent value of interdisciplinary research and the enhanced potential created when two such entities join forces.

"Professor Marth will invigorate interdisciplinary biomedical research at UC Santa Barbara, not only with his own exciting research in the Molecular, Cellular and Developmental Biology Department, but also with expansion of the Burnham Institute at UCSB," said Dennis O. Clegg, co-director of UCSB's Center for Stem Cell Biology and Engineering, and professor and recent past chair of MCDB. "Burnham is one the premier forces in medical research in the world, and expansion of the partnership with UCSB will enable novel approaches to uncover the molecular mechanisms of disease."

####

About University of California, Santa Barbara
About Engineering and the Sciences at UCSB

Engineering and the sciences at UC Santa Barbara are considered leaders in bioengineering, chemical and computational engineering, marine and environmental science, materials science, nanotechnology, and physics. UCSB has five Nobel laureates on its faculty.

About the Carbon Chair and the Mellichamp Chair

Endowed chairs are highly prized academic positions established with philanthropic gifts. They enable a university to recruit and retain outstanding faculty and to develop more fully a field of study by providing chair holders with ongoing financial support for enhanced research and instruction. The John Carbon Chair is named in honor of UCSB Emeritus Professor John Carbon, a pioneering biochemist who made numerous contributions to advance medical research. Carbon served as one of the original scientific advisors to Amgen. The chair was established by the Amgen Foundation, the William K. Bowes, Jr. Foundation, the Franklin and Catherine Johnson Foundation, and the Rathmann Family Foundation. The Mellichamp Chair was created by Emeritus UCSB Chemical Engineering Professor Duncan Mellichamp and his wife, Suzanne, to support research in the emerging field of systems biology.

About Burnham Institute for Medical Research

Burnham Institute for Medical Research is dedicated to discovering the fundamental molecular causes of disease and devising the innovative therapies of tomorrow. Burnham, with operations in California and Florida, is one of the fastest growing research institutes in the country. The institute ranks among the top four institutions nationally for NIH grant funding. For the past decade (1999-2009), Burnham has ranked number one worldwide in the fields of biology and biochemistry for the impact of its research publications (defined by citations per publication), according to the Institute for Scientific Information. Burnham utilizes a unique, collaborative approach to medical research and has established major research programs in cancer, neurodegeneration, diabetes, and infectious, inflammatory, and childhood diseases. The institute is especially known for its world-class capabilities in stem cell research and drug discovery technologies.

For more information, please click here

Contacts:
Eileen Conrad
805-893-8726

Josh Baxt
858-795-5236

Copyright © University of California, Santa Barbara

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

SEMATECH to Showcase Innovation and Advances in Manufacturing at SEMICON Japan 2014: SEMATECH experts will share the latest techniques, emerging trends and best practices in advanced manufacturing strategies and methodologies November 26th, 2014

Australian startup creates world’s first 100% cotton hydrophobic T-Shirts November 26th, 2014

The mysterious 'action at a distance' between liquid containers November 26th, 2014

'Giant' charge density disturbances discovered in nanomaterials: Juelich researchers amplify Friedel oscillations in thin metallic films November 26th, 2014

Nanomedicine

Vegetable oil ingredient key to destroying gastric disease bacteria: In mice, therapeutic nanoparticles dampen H. pylori bacteria and inflammation that lead to ulcers and gastric cancer November 25th, 2014

Research reveals how our bodies keep unwelcome visitors out of cell nuclei November 24th, 2014

ASU, IBM move ultrafast, low-cost DNA sequencing technology a step closer to reality November 24th, 2014

An Inside Job: UC-Designed Nanoparticles Infiltrate, Kill Cancer Cells From Within November 24th, 2014

Sensors

Lawrence Livermore researchers develop efficient method to produce nanoporous metals November 25th, 2014

Cooling with the coldest matter in the world November 24th, 2014

Canatu Launches CNB In-Mold Film for Transparent Touch on 3D Surfaces –in Cars, Household Appliances, Wearables, Portables November 20th, 2014

UO-industry collaboration points to improved nanomaterials: University of Oregon microscope puts spotlight on the surface structure of quantum dots for designing new solar devices November 20th, 2014

Announcements

SEMATECH to Showcase Innovation and Advances in Manufacturing at SEMICON Japan 2014: SEMATECH experts will share the latest techniques, emerging trends and best practices in advanced manufacturing strategies and methodologies November 26th, 2014

Australian startup creates world’s first 100% cotton hydrophobic T-Shirts November 26th, 2014

The mysterious 'action at a distance' between liquid containers November 26th, 2014

'Giant' charge density disturbances discovered in nanomaterials: Juelich researchers amplify Friedel oscillations in thin metallic films November 26th, 2014

Appointments/Promotions/New hires/Resignations/Deaths

Mining entrepreneur Julian Malnic Joins Deep Space Industries’ Board: Deep Space Industries welcomes a prolific mining entrepreneur and accomplished company builder, Julian Malnic, to its Board of Directors November 14th, 2014

SEMATECH Names Ronald Goldblatt Permanent Chief Executive Officer November 7th, 2014

First Canada Excellence Research Chair gets $10 million from the federal government for oilsands research at the University of Calgary: Federal government announces prestigious research chair to study improving oil production efficiency October 19th, 2014

VDMA photonics steering committee with new members stronger than ever October 14th, 2014

Nanobiotechnology

Quantum mechanical calculations reveal the hidden states of enzyme active sites November 20th, 2014

Tokyo Institute of Technology research: Protein-engineered cages aid studies of cell functions November 19th, 2014

A novel method for identifying the body’s ‘noisiest’ networks November 19th, 2014

Implementation of DNA Chains in Designing Nanospin Pieces November 9th, 2014

Alliances/Partnerships/Distributorships

SEMATECH to Showcase Innovation and Advances in Manufacturing at SEMICON Japan 2014: SEMATECH experts will share the latest techniques, emerging trends and best practices in advanced manufacturing strategies and methodologies November 26th, 2014

New research project supports internationalisation in nano-research: Launch of new “Baltic Sea Network” November 22nd, 2014

UO-industry collaboration points to improved nanomaterials: University of Oregon microscope puts spotlight on the surface structure of quantum dots for designing new solar devices November 20th, 2014

A novel method for identifying the body’s ‘noisiest’ networks November 19th, 2014

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More












ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE